Caption Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-537,700
Closed -$31.3M 1581
2025
Q4
$29M Buy
+537,700
New +$25.9M 0.2% 112
2025
Q3
Sell
-9,100
Closed -$425K 1682
2025
Q2
$421K Buy
+9,100
New +$447K ﹤0.01% 1154
2024
Q1
Sell
-2,300
Closed -$118K 1226
2023
Q4
$118K Sell
2,300
-357,700
-99% -$18.8M ﹤0.01% 1165
2023
Q3
$20.9M Buy
360,000
+10,600
+3% +$649K 0.32% 65
2023
Q2
$22.3M Buy
349,400
+91,200
+35% +$6.12M 0.4% 48
2023
Q1
$17.9M Buy
258,200
+32,350
+14% +$2.28M 0.35% 63
2022
Q4
$16.2M Buy
+225,850
New +$17M 0.25% 94
2021
Q1
Sell
-900
Closed -$56K 1065
2020
Q4
$56K Sell
900
-12,500
-93% -$769K ﹤0.01% 911
2020
Q3
$808K Buy
13,400
+5,800
+76% +$349K 0.02% 681
2020
Q2
$447K Sell
7,600
-6,400
-46% -$383K 0.01% 691
2020
Q1
$781K Buy
14,000
+5,800
+71% +$355K 0.04% 462
2019
Q4
$515K Buy
+8,200
New +$470K 0.02% 621
2019
Q3
Sell
-5,000
Closed -$235K 716
2019
Q2
$227K Sell
5,000
-270,000
-98% -$12.6M 0.01% 555
2019
Q1
$13.1M Buy
275,000
+265,500
+2,795% +$13.2M 0.72% 22
2018
Q4
$494K Buy
+9,500
New +$510K 0.04% 337
2018
Q1
Sell
-40,000
Closed -$2.45M 229
2017
Q4
$2.45M Buy
+40,000
New +$2.5M 0.25% 111

Other funds holding BMY

Caption Management's BMY Position: Q1 2026 in Review

Caption Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 537,700 shares — an estimated $31.3M sold.

Caption Management first reported a position in BMY in Q4 2017 and held it in 16 quarters. The position peaked at $29M in Q4 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Caption Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 537,700 Bristol-Myers Squibb shares in Q1 2026, an estimated $31.3M.
  • Caption Management first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 16 quarters.
  • Caption Management's Bristol-Myers Squibb position peaked at $29M in Q4 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.